(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-07 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1586540
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Thu Nov 2024 | 51.88 | 51.40 | 53.26 | 51.15 | 1.007 times |
| 06 Wed Nov 2024 | 50.72 | 51.80 | 51.88 | 49.39 | 1.435 times |
| 05 Tue Nov 2024 | 50.36 | 49.35 | 50.42 | 47.04 | 1.369 times |
| 04 Mon Nov 2024 | 50.59 | 50.44 | 51.90 | 49.21 | 1.01 times |
| 01 Fri Nov 2024 | 50.76 | 46.96 | 50.85 | 46.91 | 1.427 times |
| 31 Thu Oct 2024 | 46.39 | 47.76 | 47.99 | 46.30 | 0.806 times |
| 30 Wed Oct 2024 | 47.93 | 48.51 | 49.87 | 47.60 | 0.735 times |
| 29 Tue Oct 2024 | 48.94 | 49.53 | 49.75 | 48.44 | 0.747 times |
| 28 Mon Oct 2024 | 49.71 | 47.99 | 50.50 | 47.75 | 1.076 times |
| 25 Fri Oct 2024 | 47.36 | 47.96 | 48.88 | 47.26 | 0.699 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 52.1, for a target of 50.2 or 48.7
Share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Target | 43.42 |
| Downside Target | 44.44 |
| Downside Target | 48.94 |
| Downside Target | 50.50 |
| Downside Target | 50.85 |
| Upside Target | 51.99 |
| Upside Target | 52.31 |
| Upside Target | 53.26 |
| Upside Target | 57.68 |
| Upside Target | 63.68 |
Intraday share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Intraday Target | 48.19 |
| Downside Intraday Target | 44.51 |
| Upside Intraday Target | 54.41 |
| Upside Intraday Target | 56.95 |
| Downside Intraday Target | 50.73 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Thu Nov 2024 | 51.88 | 50.44 | 53.26 | 47.04 | 1.006 times |
| 01 Fri Nov 2024 | 50.76 | 47.99 | 50.85 | 46.30 | 1.342 times |
| 25 Fri Oct 2024 | 47.36 | 48.59 | 48.94 | 45.44 | 1.167 times |
| 18 Fri Oct 2024 | 48.92 | 46.74 | 49.28 | 46.10 | 1.151 times |
| 11 Fri Oct 2024 | 46.85 | 45.43 | 47.50 | 44.44 | 0.773 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Thu Nov 2024 | 51.88 | 46.96 | 53.26 | 46.91 | 0.403 times |
| 31 Thu Oct 2024 | 46.39 | 47.00 | 50.50 | 44.44 | 1.167 times |
| 30 Mon Sep 2024 | 46.98 | 47.37 | 51.99 | 43.42 | 0.769 times |
| 30 Fri Aug 2024 | 47.72 | 57.39 | 57.68 | 44.80 | 0.967 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 49.78 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 49.78 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.